Code of Massachusetts Regulations
105 CMR - DEPARTMENT OF PUBLIC HEALTH
Title 105 CMR 300.000 - Reportable Diseases, Surveillance, and Isolation and Quarantine Requirements
Section 300.171 - Reporting of Antimicrobial Resistant Organisms and Cumulative Antibiotic Susceptibility Test Results (Antibiograms)

(A) All Laboratories shall report results indicating antimicrobial resistance in the following organisms directly to the Department through secure electronic laboratory reporting mechanisms, or other method, as defined by the Department. Information shall include the name of a laboratory contact, the specified test results, date of specimen collection, source of specimen, and the case's full name, date of birth, sex, race and ethnicity, full address, telephone number, and name of the ordering health care provider, when available.

Carbapenemase-producing and/or carbapenem-resistant Enterobacteriacea

Neisseria gonorrhoeae resistant to ceftriaxone

Vancomycin-resistant Staphylococcus aureus (VRSA)

Vancomycin-intermediate Staphylococcus aureus (VISA)

Invasive methicillin-resistant Staphyloccus aureus (MRSA)

Invasive penicillin-resistant Streptococcus pneumoniae

If antimicrobial resistance of an unexplained or novel nature is identified in any infectious organism, the laboratory must contact the Department within five business days.

(B) All hospitals shall report annual cumulative antibiotic susceptibility test results (antibiograms). This report shall include information specified by the Department and be sent in the manner deemed acceptable by the Department.